SEATTLE, WA, DexCare, a leading patient demand and care access platform, announced the close of its $75 million Series C funding round led by ICONIQ Growth.
DexCare, a leading patient demand and care access platform, announced the close of its $75 million Series C funding round led by ICONIQ Growth.
The funding round included participation from existing partners Transformation Capital, Kaiser Permanente Ventures, Define Ventures, Frist Cressey Ventures, and SpringRock Ventures.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our
about page.
